Appropriateness of indirect markers of muscle damage following lower limbs eccentric-biased exercises: A systematic review with meta-analysis.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
16
03
2022
accepted:
25
06
2022
entrez:
14
7
2022
pubmed:
15
7
2022
medline:
19
7
2022
Statut:
epublish
Résumé
The aim of this review was to (1) characterize the time-course of markers of exercise-induced muscle damage (EIMD) based on the level of maximal voluntary contraction torque loss at 24-48h post-exercise (MVCloss24-48h), (2) identify factors (e.g., exercise and population characteristics) affecting the level of MVCloss24-48h, and (3) evaluate the appropriateness of EIMD markers as indicators of MVCloss24-48h. Magnitude of change of each EIMD markers was normalized using the standardized mean differences method to compare the results from different studies. Time-course of EIMD markers were characterized according to three levels of MVCloss24-48h based on a clustering analysis of the 141 studies included. Association between MVCloss24-48h levels and participant´s characteristics or exercise type/modalities were assessed. Meta-regressions were performed to investigate the associations between MVCloss24-48h and EIMD markers changes at <6h, 24h, 48h, 72h and >96h after exercise. Time-course of EIMD markers recovery differs between levels of MVCloss24-48h. Training status and exercise type/modality were associated with MVCloss24-48h level (p<0.05). MVCloss24-48h was correlated to changes in myoglobin concentration (<6h), jump height (24h) and range of motion (48h) (p<0.001). As the exercise could differently affect markers as function of the EIMD severity (i.e., MVCloss24-48h levels), different markers should be used as function of the timing of measurement. Mb concentration should be used during the first hours after the exercise (<6h), whereas jump height (24h) and range of motion (48h) could be used as surrogate for maximal voluntary contraction later. Moreover, training status and exercise type/modality could influence the magnitude of MVCloss24-48h.
Identifiants
pubmed: 35834532
doi: 10.1371/journal.pone.0271233
pii: PONE-D-22-07742
pmc: PMC9282447
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0271233Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Eur J Appl Physiol. 2022 Feb;122(2):489-502
pubmed: 34799753
J Physiol. 1993 May;464:183-96
pubmed: 8229798
J Strength Cond Res. 2002 May;16(2):202-8
pubmed: 11991771
Sports Med. 1995 Jun;19(6):401-17
pubmed: 7676101
J Epidemiol Community Health. 1998 Jun;52(6):377-84
pubmed: 9764259
Eur J Cell Biol. 2020 Nov;99(8):151127
pubmed: 33162173
Exerc Immunol Rev. 2006;12:6-33
pubmed: 17201070
J Appl Physiol (1985). 2014 Jun 1;116(11):1426-34
pubmed: 23823152
Biol Sport. 2016 Sep;33(3):285-9
pubmed: 27601784
Acta Physiol Scand. 1999 Jan;165(1):57-63
pubmed: 10072098
Am J Phys Med Rehabil. 2002 Nov;81(11 Suppl):S52-69
pubmed: 12409811
Physiol Rev. 2001 Oct;81(4):1725-89
pubmed: 11581501
J Funct Morphol Kinesiol. 2021 Nov 24;6(4):
pubmed: 34842737
Sports Med. 1999 Jan;27(1):43-59
pubmed: 10028132
Clin Sports Med. 2012 Apr;31(2):255-62
pubmed: 22341015
Med Sci Sports Exerc. 2015 Jul;47(7):1372-82
pubmed: 25304334
Br J Sports Med. 2009 Aug;43(8):556-68
pubmed: 18981046
Clin Chem Lab Med. 2010 Jun;48(6):757-67
pubmed: 20518645
Int J Sports Med. 2016 Jul;37(8):633-40
pubmed: 27116346
Int J Sports Med. 2014 Dec;35(14):1190-5
pubmed: 25259592
J Sci Med Sport. 2016 Jun;19(6):438-53
pubmed: 26304796
Front Med (Lausanne). 2015 Jul 09;2:45
pubmed: 26217665
Eur J Sport Sci. 2014;14(3):242-50
pubmed: 24655147
Int J Exerc Sci. 2021 Apr 01;14(7):1-18
pubmed: 34055176
J Appl Physiol (1985). 2002 May;92(5):1995-2004
pubmed: 11960950
Scand J Med Sci Sports. 2015 Jun;25(3):417-27
pubmed: 24798498
Clin Chem Lab Med. 2018 Dec 19;57(2):175-182
pubmed: 30173201
J Appl Physiol (1985). 2001 Dec;91(6):2686-94
pubmed: 11717235
Clin Rehabil. 2010 Jul;24(7):590-9
pubmed: 20530649
Med Sci Sports Exerc. 2005 May;37(5):737-45
pubmed: 15870626
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Rev Esp Cardiol (Engl Ed). 2021 Sep;74(9):790-799
pubmed: 34446261
Exerc Immunol Rev. 2012;18:42-97
pubmed: 22876722
J Sports Med Phys Fitness. 2020 Mar;60(3):449-455
pubmed: 31958001
Acta Physiol Scand. 1994 Nov;152(3):265-77
pubmed: 7872004
P T. 2008 Dec;33(12):700-11
pubmed: 19750051
Exerc Immunol Rev. 1999;5:5-21
pubmed: 10519060
J Funct Morphol Kinesiol. 2019 Sep 27;4(4):
pubmed: 33467382
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834